News Breaks |
|
|
| October 4, 2012 |
| 06:46 EDT |  | SRPT, PPHM | Stocks with implied volatility below IV index mean; PPHM SRPT Stocks with implied volatility below IV index mean; Peregrine Pharmaceuticals (PPHM), Sarepta (SRPT) according to iVolatility. |
|
|
News For SRPT;PPHM From The Last 14 Days Check below for free stories on SRPT;PPHM the last two weeks. |
|
|
| May 21, 2013 |
| 07:34 EDT |  | SRPT | UBS to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 08:50 EDT |  | PPHM | Peregrine reaches agreement with FDA on Phase 3 trial design for Bavituximab Peregrine Pharmaceuticals announced that it has reached agreement with the FDA on a Phase III registration trial design of the company's lead clinical immunotherapeutic candidate bavituximab in second-line non-small cell lung cancer. The trial design was supported by promising data from a Phase IIb trial in patients treated with bavituximab plus docetaxel. The Phase III clinical trial will be a randomized, double-blind, placebo-controlled trial evaluating bavituximab plus docetaxel versus docetaxel alone enrolling approximately 600 patients at sites worldwide. The trial will enroll Stage IIIB/IV non-squamous, NSCLC patients who have progressed after standard front-line treatment. The primary endpoint of the trial will be overall survival. |
|
| 08:40 EDT |  | PPHM | Peregrine trading halted, pending news
Subscribe for More Information |
|
| May 16, 2013 |
| 07:29 EDT |  | SRPT | Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 9, 2013 |
| 12:21 EDT |  | SRPT | Sarepta climbs after saying documents to be submitted this month
Subscribe for More Information |
|
| 07:29 EDT |  | SRPT | Sarepta reports Q1 EPS (41c), consensus (62c) Reports Q1 revenue $4.5M, consensus $5.85M. |
|
| May 7, 2013 |
| 13:15 EDT |  | SRPT | Options with increasing implied volatility: CVRR SRPT PGH TWO GDI HNZ
Subscribe for More Information |
|
| 08:59 EDT |  | SRPT | Sarepta initiates dosing in Phase I study of Marburg virus treatment
Subscribe for More Information |
|
|
|
|
|